Brynja Gudmundsdottir
- May 17, 2021
- 1 min read

Read about our new publication in Blood about the stunning result from our comparative study

In this study we compare patients on warfarin anticoagulation but managed by two different monitoring tests.

Group 1 is monitored by Owren PT but group 2 is is monitored by the new Fiix test.

This resulted in 50 % fewer thrombotic event in the Fiix group

Recent Posts

Could the Fiix normalized ratio (Fiix PT) save taxpayer´s money and insurance premiums?

The answer is yes. Because the Fiix-PT improves the effectiveness of warfarin markedly without reducing safety. See the publications list for the arguments behind this statement. The cost of drugs fo

Fiix-warfarin is different from ordinary warfarin: Death and disability is reduced.

Two publications from the team in 2019

A new warfarin initiation protocol for safe Fiix dose management. J Thromb Thrombolysis A review article on anticoagulant monitoring: Oral anticoagulant monitoring: Are we on the right track? Int J L

FIIX DIAGNOSTICS LTD

Aiming to reduce death and disability

Read about our new publication in Blood about the stunning result from our comparative study

Recent Posts